CytoDyn (OTC: CYDY) and the Mexican National Institutes of Health Participate in a Collaborative Study of Leronlimab for the Treatment of Severe/Critical COVID-19 Population
VANCOUVER, Washington, May 19, 2020– The study is anticipated to consist of approximately thirty patients with potential involvement of the NIH of Mexico in other CytoDyn trials VANCOUVER, Washington, May 19, 2020 — CytoDyn Inc. (OTC.QB: CYDY), […]
